Amgen settles shareholder lawsuit claiming it hid $10.7 billion tax bill - Reuters
Amgen settles shareholder lawsuit claiming it hid $10.7 billion tax bill Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPX3YtTFY5b1JGWk5hRmNILXdxSllxZ0hBSnhjVGREdndkQVo3d0VDU0FwWlYxTU40LWVoTVp6OGZHcUM3XzFEMFZ1OFg5NEZzSG9LUkxueUd1U3ZIV1NTanc0cFFPUEpRUHFMa3BDRG9tN0lYOU1FajhXY21KY1RBUkRmTzRZX3lxcFU4MG83NFdLTy1DTGprM2UyNmZFSDFLZ0hBclNnWnFRcklzNG5nYWY2MGp0Z3JvbUVZSTZUX1k?oc=5" target="_blank">Amgen settles shareholder lawsuit claiming it hid $10.7 billion tax bill</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen - Reuters
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen Reuters
October 2, 2026 at 10:57 AMSanofi to pay Regeneron $1 billion upfront in expanded immunology deal - Reuters
Sanofi to pay Regeneron $1 billion upfront in expanded immunology deal Reuters
October 1, 2026 at 05:17 AMCigna expects $3 billion in cost savings by 2030 - Reuters
Cigna expects $3 billion in cost savings by 2030 Reuters
September 30, 2026 at 03:06 PMBayer to invest $2.2 billion in new US pharma site - Reuters
Bayer to invest $2.2 billion in new US pharma site Reuters
October 2, 2026 at 07:19 PMBank of America to pay $39 million to settle customer claims over low interest rates on cash - reuters.com
Bank of America to pay $39 million to settle customer claims over low interest rates on cash reuters.com
September 30, 2026 at 10:52 PMMerck licenses SciBrunch cancer drug in deal worth up to $2.13 billion - Reuters
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion Reuters
September 28, 2026 at 04:14 PM